Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma

Institut Salah Azaiez, Bab Saadoun

Hopital Abderrahman Mami de Pneumo-Phtisiologie de l'Ariana, Aryanah

Hospital Habib Bourguiba, Sfax

Istituto Nazionale Dei Tumori, Milan

Hospital Universitario Madrid Sanchinarro, Madrid

Levine Cancer Institute, Charlotte

Winship Cancer Institute of Emory University, Atlanta

Hospital Universitario de Salamanca, Salamanca

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

Thermi Clinic, Thessaloniki

University of Chicago, Chicago

Columbia Comprehensive Cancer Care Clinic, Jefferson City

University General Hospital of Heraklion, Heraklion

Institut Curie, Paris

Chang Gung Medical Foundation, Kaohsiung Memorial Hospital, Niao-Sung Hsiang Kaohsiung County

Institut Hospitalier Franco-Britannique, Levallois-Perret

Institut Gustave Roussy, Villejuif

Singapore Oncology Consultants, Singapore

Johns Hopkins Singapore International Medical Centre, Singapore

Dana Farber Cancer Institute, Boston

Princess Margaret Cancer Centre, Toronto

McGill University, Montreal

National Cancer Center, Singapore

Instituto Catalan de Oncologia-Hospital Duran, Barcelona